↓ Skip to main content

The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review

Overview of attention for article published in Frontiers in Pharmacology, November 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
twitter
8 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review
Published in
Frontiers in Pharmacology, November 2021
DOI 10.3389/fphar.2021.751214
Pubmed ID
Authors

Aurélie Pahud de Mortanges, Dante Salvador, Markus Laimer, Taulant Muka, Matthias Wilhelm, Arjola Bano

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 12%
Student > Master 6 12%
Student > Bachelor 6 12%
Other 5 10%
Student > Ph. D. Student 2 4%
Other 6 12%
Unknown 21 40%
Readers by discipline Count As %
Medicine and Dentistry 21 40%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Unspecified 2 4%
Agricultural and Biological Sciences 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 0 0%
Unknown 23 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2024.
All research outputs
#2,109,745
of 25,791,495 outputs
Outputs from Frontiers in Pharmacology
#864
of 20,013 outputs
Outputs of similar age
#47,679
of 446,428 outputs
Outputs of similar age from Frontiers in Pharmacology
#41
of 1,144 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,013 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,428 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1,144 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.